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injection of LPS and displayed an activated morphology with retracted processes, but these 
changes were not different from similarly treated naïve mice (F(1,10) = 0.53 n.s.). Similar 
results were observed for CD11b expression levels (Figure 7). In contrast, focal injection of 
LPS into the brain of previously SL3261-infected animals led to higher expression levels of 
CD11c (Figure 6A-D and 7, interaction: F(1,12) = 5.59 p < 0.05), MHCII (Figure 6L and 7, 
interaction: F(1,14) = 10.0 p < 0.01), and MHCI (Figure 7, interaction: F(1,14) = 1.11 n.s.). 
Microglia or macrophages in the parenchyma showed expression of CD11c which was not 
detected on microglia of naïve mice (Figure 6A-D).  In addition, there appeared to be an 
increased number of CD11c+ cells in the perivascular space of SL3261 pre-treated mice, 
suggesting  possible  recruitment  of  myeloid  cells  from  the  circulation  (Figure  6D).  The 
cerebral vasculature of mice infected with SL3261 four weeks previous to the LPS challenge 
remained positive for MHCII (Figure 6K and 6O) and intracerebral injection of LPS induced 
MHCII expression on parenchymal microglia/macrophages. This observation was confirmed 
by a double staining with laminin to differentiate MHCII+ microglial cells from MHCII+ 
endothelial cells of the vasculature (Figure 6P).      22 
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